Market Tracker

06/28 10:05am ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

0.66
Delayed Data
As of 9:50am ET
 +0.0403 / +6.50%
Today’s Change
0.43
Today|||52-Week Range
2.00
-46.34%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.62
Today’s open0.62
Day’s range0.60 - 0.68
Volume142,903
Average volume (3 months)299,397
Market cap$24.0M
Dividend yield--
Data as of 9:50am ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book0.52

Competitors

 Today’s
change
Today’s
% change
SLNOSoleno Therapeutics ...0.000.00%
XBIOXenetic Biosciences ...-0.13-4.83%
AXNAoxing Pharmaceutica...+0.00+0.03%
ABIOARCA Biopharma Inc0.000.00%
Data as of 9:47am ET, 06/28/2017

Financials

Next reporting dateSeptember 14, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts